Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Gland Pharma Ltd. ( (IN:GLAND) ).
Gland Pharma Limited has announced a significant change in its leadership structure. Effective January 16, 2025, Mr. Shyamakant Giri will take over as the Chief Executive Officer. Mr. Srinivas Sadu will continue his role as Executive Chairman, supporting the company’s future growth plans. This leadership transition indicates a strategic move to bolster Gland Pharma’s operations and growth trajectory, potentially impacting its market positioning positively.
More about Gland Pharma Ltd.
YTD Price Performance: -7.85%
Average Trading Volume: 12,481
Current Market Cap: 274.8B INR
For a thorough assessment of GLAND stock, go to TipRanks’ Stock Analysis page.